Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Exogenous Ketosis on Proteinuria and Renal Function
Sponsor: Gødstrup Hospital
Summary
A randomized, placebo-controlled, double-blinded crossover study will be conducted. Fourteen patients with polycystic kidney disease (PKD) and 29 patients with proteinuric kidney disease will receive ketone bodies (Ketone-IQ) and placebo in a randomized order. Each treatment period is four weeks. There will be a wash-out period of two weeks in between treatment periods. Effect variables will be measured in the last day of each treatment period.
Official title: Effects of Exogenous Ketosis on Proteinuria and Renal Function in Patients with Chronic Kidney Disease and Patients with Polycystic Kidney Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
43
Start Date
2024-09-11
Completion Date
2025-12
Last Updated
2025-03-10
Healthy Volunteers
No
Interventions
Ketone Diol, R-1,3-butanediol (Ketone-IQ)
Effect variables will be measured on the last day of treatment with Ketone-IQ
Placebo drink
Effect variables will be measured on the last day of treatment with Placebo
Locations (1)
University Clinic in Nephrology and Hypertension, Gødstrup Region Hospital
Herning, Jutland, Denmark